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COMMENTARY
New insights on the association 
between the prostate cancer and the small DNA 
tumour virus, BK polyomavirus
Mauro Tognon1* and Maurizio Provenzano2
Abstract 
In recent years the scientific literature in the field of the prostate carcinoma (PCa) pointed out on the genetic het-
erogeneity and mutations occurring in this tumour, while little attention was given to the causes of PCa onset, in 
particular infectiuos agents. In this brief commentary, we wish to point out recent advancements done on the role 
of the human polyomavirus BK (BKPyV) in the development of PCa by harnessing both humoral and cellular immune 
responses. Altogether, these new insights suggest that BKPyV is involved in the transforming activity during the multi-
step process of PCa development. Although these findings do not provide evidence for a causal relationship between 
BKPyV and PCa development, additional investigations with novel techniques will help to make it a concrete event.
© 2015 Tognon and Provenzano. This article is distributed under the terms of the Creative Commons Attribution 4.0 International 
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any 
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons 
license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.
org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
In recent years the scientific literature in the field of the 
prostate carcinoma (PCa) pointed out on the genetic het-
erogeneity and mutations occurring in this tumour [1, 
2], while little attention was given to the causes of PCa 
onset. Together with chemical and physical agents, bio-
logical agents such as viruses with oncogenic potential, 
which interfere with the cell cycle, are responsible for 
gene alterations and might be included in the putative 
genomic evolution of PCa.
Herein, we wish to draw the attention of the readers to 
the role of the human polyomavirus BK (BKPyV) in the 
development of PCa. BKPyV encodes two viral onco-
genes, the large T antigen (Tag) and small t antigen (tag). 
Transformation of animal and human cells by BKPyV is 
operated by these two viral oncoproteins [3]. Tag binds 
and abolishes the functions of the tumour suppressor 
p53 and pRB family proteins, whereas tag interacts with 
the phosphatase PP2A, which activates the Wnt path-
way [4]. Moreover, tag activates the phosphatidylinositol 
3-kinase, an enzyme involved in pathways crucial for cell 
proliferation and transformation. Tag is also clastogenic 
and mutagenic [3]. These activities are able to hit the cel-
lular genome, which accumulates many gene mutations/
chromosome aberrations. Then, in the absence of p53 
functions, due to Tag binding, the cellular DNA remains 
unrepaired with the consequence that the genome 
“derailed”. In addition, loss-of-function mutations in p53 
gene at very early stages of PCa are rare [1]. Therefore, 
the sequestration of wild-type p53 exerted by BKPyV 
Tag oncoprotein at initial phases is a hallmark for BKPyV 
involvement [5]. These mechanisms may ensure the 
genetic heterogeneity of PCa.
In this context, it is worth noting that the WHO classi-
fied BKPyV as “possibly carcinogenic to human” (http://
monographs.iarc.fr/ENG/Monographs/vol104/mono104.
pdf) because of the sufficient evidence of its carcino-
genicity in vitro and/or in vivo in animal [6]. However, at 
present  there are not sufficient human epidemiological 
data to support so.
Considering that BKPyV infection is ubiquitous in the 
general population, it is difficult to assess a specific role 
of this virus in cellular transformation. BKPyV is kidney-
tropic and remains latent in many human organs/tissues, 
including the prostate. The lifelong period of BKPyV 
infection, together with the fact that about 95 % of PCa 
are slow-growing organ-confined indolent tumors, 
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could be responsible of those gene/chromosomal dam-
ages, which initiate the development of this malignancy. 
BKPyV infection has repeatedly been associated with 
PCa and BKPyV Tag was identified as a potential co-fac-
tor at the earliest stages of this disease [5]. Footprints of 
this small DNA tumour virus has been revealed in pre-
cursor inflammatory lesions [7], which may evolve in 
prostatic intraepithelial neoplasia (PIN) and then in overt 
PCa [8] Indeed, BKPyV was detected at higher preva-
lence in early stages PCa than in healthy control tissues, 
thus providing an indication for an increased risk of PCa 
development with the presence of BKPyV infection [9]. 
Notably, a peculiar cellular immune response elicited by 
BKPyV LTag has been observed in PCa patients with evi-
dence of biochemical recurrence that bear BKPyV LTag 
positive tumors [10]. In addition, immunological data 
indicate that antibody response to BKPyV Tag in PCa 
patients at first diagnosis might associate with the clinical 
course of this disease [11].
Altogether, these data suggest that BKPyV Tag, as a 
viral oncogene, is involved in the transforming activity 
during the multistep process of PCa development [12]. 
However, additional investigations with novel techniques 
are needed in order to be more persuasive on the role of 
BKPyV in PCa.
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